comparemela.com

Page 6 - Immunology Annual Meeting News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biologics and Aspirin-Exacerbated Respiratory Disease

Biologics may be effective in treating aspirin-exacerbated respiratory disease, with dupilumab having the highest odds of being reported as effective by patients.

United statesAmerican academy of allergyAmerican academyImmunology annual meetingPulmonology advisor

COVID-19 Mortality and Obstructive Airway Diseases

Patients hospitalized with COVID-19 with comorbid asthma, COPD, and ACO had significantly higher mortality than patients without these comorbidities.

United statesAmerican academy of allergyAmerican academyImmunology annual meetingPulmonology advisor

Azithromycin and Recurrent Wheeze in Children After Severe RSV Bronchiolitis

Although oral azithromycin attenuates airway inflammation during RSV bronchiolitis in children, it does not reduce long-term risk of recurrent wheeze.

United statesBeigelmana srinivasanAmerican academy of allergyAmerican academyImmunology annual meetingAdjusted hazard ratio

Allergy Therapeutics shares positive new data at 2022 American Academy of Allergy Asthma

Allergy Therapeutics shares positive new data at 2022 American Academy of Allergy Asthma

City ofUnited kingdomUnited statesMohamed shamjiManuel llobetImperial college londonAmerican academy of allergy asthmaAllergy therapeuticsAllergy asthmaImmunology annual meetingAllergy therapeuticschief executive officer

Allergy Therapeutics PLC posts improved results from hay fever study

Allergy Therapeutics PLC (AIM:AGY) has presented new data showing the use of its grass pollen vaccine can cut hay fever symptoms by around 40%. Posters from.

United statesManuel llobetAllergy therapeuticsAmerican academy of allergy asthmaAllergy asthmaImmunology annual meeting

vimarsana © 2020. All Rights Reserved.